Stock Groups

DuPont De Nemours Earnings, Revenue Beat in Q3 -Breaking

[ad_1]

© Reuters. DuPont De Nemours Earnings, Revenue Beat in Q3

Investing.com. DuPont. (NYSE:). De Nemours released Tuesday’s third quarter report. It beat forecasts by analysts and generated revenue above expectations.

DuPont De Nemours reported earnings per share at $1.15 for revenue of $4.27B. Investing.com polled analyst to predict EPS at $1.12 on revenues of $4.16B.

DuPont De Nemours shares have fallen 0% since the start of the year. However, they are still 18.38% below their 52-week high of $87.27 on January 12. They are under-performing the S&P 500 which is up 22.83% from the start of the year.

DuPont De Nemours reports on other important earnings from the Healthcare sector this month

DuPont De Nemours’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Thermo Fisher Scientific beat all expectations with a third quarter EPS at $5.76 on revenues of $9.33B. This compares to a forecast of EPS at $4.68 for revenue of $8.38B.

You can keep up-to date on the latest earnings reports by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts, buy/sell signal, and quotes. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]